Catalyst Pharmaceuticals Named BioFlorida 2022 Company of the Year

November 7, 2022

https://www.globenewswire.com/news-release/2022/11/07/2549681/13009/en/Catalyst-Pharmaceuticals-Named-BioFlorida-2022-Company-of-the-Year.html

CORAL GABLES, Fla., Nov. 07, 2022 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst”) (Nasdaq:CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, today announced that it has been named the “2022 David J. Gury Company of the Year” by BioFlorida. The award recognizes one company that accomplishes significant milestones and achievements leading to the advancement of life sciences in Florida.

Read more at globenewswire.com

Related news for (CPRX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.